Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
CA 2307846 A1 · Owner: Peek, Joel A. · Inventors: Griffais, Remy; Zagursky, Robert J.; Sankaran, Banumathi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of Chlamydia pneumoniae such as cellular , envelope polypeptides which are secreted or specific, or which are involved in metabolism, in the replication process or in virulence polypeptides , encoded by such sequences as well as vectors including the said sequences and cells or animals transformed with these vectors. The invention also relates to transcriptional gene products of the Chlamydia pneumoniae genome such as, for , example, antisense and ribozyme molecules which can be used to control growth , of the microorganism. The invention also relates to methods of detecting these …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.